TRIA BIOSCIENCE CORPORATION

Company Information

Company Name
TRIA BIOSCIENCE CORPORATION
Address
1616 EASTLAKE AVE E
STE 260
SEATTLE, WA, -
Phone
n/a
URL
http://triabioscience.com
DUNS
831016907
Number of Employees
7
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,888,668.00
5
SBIR Phase II
$3,000,000.00
1
Chart code to be here

Award List

  1. A novel DC-targeting non-integrating lentivector vaccine for HIV infection

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Despite two decades of persistent research on prophylactic and therapeutic immunization against HIV, an effective vaccine-based solution to the HIV pandemic has re ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Pandemic H5N1 vaccine containing recombinant H5 and a synthetic TLR4 agonist, GLA

    Amount: $756,444.00

    DESCRIPTION (provided by applicant): H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bird populations world-wide and t ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bird populations world-wide and t ...

    SBIR Phase II 2011 Department of Health and Human Services
  4. Cross-Protective Monoclonal Antibodies for treatment of pandemic Flu

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Influenza is a highly contagious respiratory disease that causes substantial mortality world-wide. There is great international concern that the Avian Influenza v ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Advanced Design of a Nicotine Vaccine for Smoking Cessation

    Amount: $352,841.00

    DESCRIPTION (provided by applicant): Tobacco smoke is the primary cause of lung cancer, cardiovascular disease and premature death, with nearly 5 million people dying each year. Treatments that preven ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Vaccine Adjuvant for Rapid Tolerance Induction in Allergy Patients

    Amount: $579,383.00

    DESCRIPTION (provided by applicant): Allergy is a major cause of illness and disability with an estimated 40-50 million people afflicted in the US alone. AIT provides long-term benefits for the patien ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government